70 results
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
10 Apr 24
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
7:02am
of preclinical studies and clinical trials; (iii) whether Nurix will be able to fund development activities and achieve development goals; (iv
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
11 Mar 24
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
7:02am
to fund development activities and achieve development goals; (v) the impact of economic and market conditions and global and regional events
8-K
EX-99.1
1rgbl42 1qvrirz1r
15 Feb 24
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
4:01pm
8-K
EX-99.2
682rd
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
4fuy0z453em681q868yb
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
uck290fszh
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
tyrclu 1oy0lr9p
11 Dec 23
Other Events
12:03pm
8-K
EX-99.1
ku2ekas
13 Nov 23
Regulation FD Disclosure
7:01am
8-K
EX-99.1
m29f 1228
12 Oct 23
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:03pm
8-K
hqu4sgdoph 6b56
7 Sep 23
Entry into a Material Definitive Agreement
7:02am
8-K
EX-99.1
y43jyrc9e9
13 Jul 23
Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:18pm
8-K
EX-99.1
w4vcszdn5ripzxy
13 Apr 23
Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:02pm
8-K
EX-99.1
mk5ng
12 Dec 22
Other Events
5:36pm